Comparison of Ho:YAG and pTm:YAG lasers in mini-percutaneous nephrolithotomy: safety, efficiency, and efficacy for lithotripsy.

Authors

Ahmet F Ozsoy, Abdulrahman Jafarov, Mehmet E Maras, Yusuf H Sahin, Atakan Atakli, Vineet Gauhar, Mehmet I Gokce

Published in

Minerva urology and nephrology. Volume 78. Issue 3. Pages 400-410.

Abstract

While several in-vitro studies have compared the performance of Holmium:YAG and pulsed Thulium:YAG lasers, no studies to date have directly compared the performance of these lasers during mini- PCNL. Herein, we aimed to compare the clinical effectiveness and stone-free rates of Ho:YAG and pThulium:YAG lasers in patients undergoing mini-PCNL.
This prospective, non-randomized study included 264 patients who underwent mini-PCNL: 170 patients in the Ho:YAG group and 94 patients in the pTm:YAG group. Demographic characteristics, stone-related variables, and intraoperative and postoperative parameters were systematically recorded.
Demographic characteristics and stone-related variables, including stone diameter, volume (mm³), and Hounsfield units, were similar between the groups; a significant difference was observed only in the GUYS score (P=0.013). Median total energy and energy consumption were significantly lower in the Ho:YAG group than in the pTm:YAG group (3954 J [1932-8630] vs. 9887 J [3961.25-21,972.75], and 1.52 J/mm³ [0.80-3.17] vs 5.03 J/mm³ [1.94-9.08], respectively; both P<0.001). Laser ablation efficiency was higher in the Ho:YAG group (0.66 mm³/J [0.31-1.24] vs. 0.20 mm³/J [0.11-0.51]; P<0.001), whereas laser efficacy was comparable between groups (61.15 vs. 55.92 mm³/min; P=0.738). Postoperative complication and stone-free rates were similar (P=0.468 and P=0.418, respectively).
Ho:YAG was associated with lower total energy use and shorter lasing times than pTm:YAG in mini-PCNL. However, overall efficacy, stone-free rates, and safety outcomes in mini-PCNL were comparable between the two laser systems.

PMID:
42438986
Bibliographic data and abstract were imported from PubMed on 13 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.